Are Loop Diaretics Putting Your Patient at Risk for Ototoxicity?

29 cases of hearing loss were reported to the fda after lasix was approved. The risk is also higher in patiente with c k d or in patients who are receiving ameno glicosites concurrently. There's also a lower risk with intervenous drips rather than bolus dosing, and that's because the serum concentrations reach much lower peaks with i v drips than they do with bullis doses.